Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

New radiotracers for imaging of vascular targets in angiogenesis-related diseases.

Hong H, Chen F, Zhang Y, Cai W.

Adv Drug Deliv Rev. 2014 Sep 30;76:2-20. doi: 10.1016/j.addr.2014.07.011. Epub 2014 Jul 30. Review.

2.

Targeted in vivo imaging of angiogenesis: present status and perspectives.

Choe YS, Lee KH.

Curr Pharm Des. 2007;13(1):17-31. Review.

PMID:
17266586
3.

Molecular imaging of αvß3 expression in cancer patients.

Gaertner FC, Schwaiger M, Beer AJ.

Q J Nucl Med Mol Imaging. 2010 Jun;54(3):309-26. Review.

PMID:
20639816
4.

Targeted molecular imaging of angiogenesis in PET and SPECT: a review.

Stacy MR, Maxfield MW, Sinusas AJ.

Yale J Biol Med. 2012 Mar;85(1):75-86. Epub 2012 Mar 29. Review.

5.
6.

Molecular cardiovascular imaging.

Dobrucki LW, Sinusas AJ.

Curr Cardiol Rep. 2005 Mar;7(2):130-5. Review.

PMID:
15717960
7.

A concise review of current radiopharmaceuticals in tumor angiogenesis imaging.

Lu X, Wang RF.

Curr Pharm Des. 2012;18(8):1032-40. Review.

PMID:
22272823
8.

Implications of PET based molecular imaging on the current and future practice of medicine.

Alavi A, Kung JW, Zhuang H.

Semin Nucl Med. 2004 Jan;34(1):56-69. Review.

PMID:
14735459
9.

New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease.

Sogbein OO, Pelletier-Galarneau M, Schindler TH, Wei L, Wells RG, Ruddy TD.

Biomed Res Int. 2014;2014:942960. doi: 10.1155/2014/942960. Epub 2014 May 11. Review.

10.
11.
12.

The role of single-photon emission computed tomography and SPECT/computed tomography in oncologic imaging.

Brandon D, Alazraki A, Halkar RK, Alazraki NP.

Semin Oncol. 2011 Feb;38(1):87-108. doi: 10.1053/j.seminoncol.2010.11.003. Review.

PMID:
21362518
13.

Targeted molecular imaging in oncology.

Yang DJ, Kim EE, Inoue T.

Ann Nucl Med. 2006 Jan;20(1):1-11. Review.

PMID:
16485568
14.

[Nuclear medicine imaging: new radiotracers and future techniques].

Semah F.

Neurochirurgie. 2008 May;54(3):231-5. doi: 10.1016/j.neuchi.2008.02.035. Epub 2008 Apr 28. Review. French.

PMID:
18440564
15.

Imaging angiogenesis.

Dobrucki LW, Sinusas AJ.

Curr Opin Biotechnol. 2007 Feb;18(1):90-6. Epub 2007 Jan 19. Review.

PMID:
17240135
16.

Single photon emission computed tomography and positron emission tomography in cancer imaging.

Coleman RE.

Cancer. 1991 Feb 15;67(4 Suppl):1261-70. Review.

PMID:
1991287
17.

New molecular targets for PET and SPECT imaging in neurodegenerative diseases.

Benadiba M, Luurtsema G, Wichert-Ana L, Buchpigel CA, Busatto Filho G.

Rev Bras Psiquiatr. 2012 Oct;34 Suppl 2:S125-36. Review. English, Portuguese.

18.

Molecular tracers for the PET and SPECT imaging of disease.

Pimlott SL, Sutherland A.

Chem Soc Rev. 2011 Jan;40(1):149-62. doi: 10.1039/b922628c. Epub 2010 Sep 1. Review.

PMID:
20818455
19.

(68)Ga-radiopharmaceuticals for PET imaging of infection and inflammation.

Kumar V, Boddeti DK.

Recent Results Cancer Res. 2013;194:189-219. doi: 10.1007/978-3-642-27994-2_11. Review.

PMID:
22918761
20.

Targeted nuclear imaging of breast cancer: status of radiotracer development and clinical applications.

Kong FL, Kim EE, Yang DJ.

Cancer Biother Radiopharm. 2012 Mar;27(2):105-12. doi: 10.1089/cbr.2011.1025. Epub 2011 Aug 30. Review.

PMID:
21877909

Supplemental Content

Support Center